Jones, R. J., Baladandayuthapani, V., Neelapu, S., Fayad, L. E., Romaguera, J. E., Wang, M., . . . Orlowski, R. Z. (2011). HDM-2 inhibition suppresses expression of ribonucleotide reductase subunit M2, and synergistically enhances gemcitabine-induced cytotoxicity in mantle cell lymphoma. American Society of Hematology.

Jones, Richard J., Veerabhadran Baladandayuthapani, Sattva Neelapu, Luis E. Fayad, Jorge E. Romaguera, Michael Wang, Rakesh Sharma, Dajun Yang, و Robert Z. Orlowski. HDM-2 Inhibition Suppresses Expression of Ribonucleotide Reductase Subunit M2, and Synergistically Enhances Gemcitabine-induced Cytotoxicity in Mantle Cell Lymphoma. American Society of Hematology, 2011.

Jones, Richard J., et al. HDM-2 Inhibition Suppresses Expression of Ribonucleotide Reductase Subunit M2, and Synergistically Enhances Gemcitabine-induced Cytotoxicity in Mantle Cell Lymphoma. American Society of Hematology, 2011.